Monitoring nutrition therapy in the critically Ill patient with obesity

Roland Dickerson, John W. Drover

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Obesity compounds the metabolic response to critical illness and augments the consequences of overfeeding. Effective monitoring is essential for the prevention of, or to avoid, worsening of preexistent morbidities associated with obesity during the implementation of specialized nutrition support. This monitoring should guide the clinician toward the selection of appropriate therapeutic options to reduce complications from significant hyperglycemia, dyslipidemia, hypercapnia, fluid overload, and worsening of hepatic steatosis. Conventional nutrition outcome markers should be employed, with their limitations understood, when used for the critically ill obese patient.

Original languageEnglish (US)
JournalJournal of Parenteral and Enteral Nutrition
Volume35
Issue number5 SUPPL.
DOIs
StatePublished - Sep 1 2011

Fingerprint

Nutrition Therapy
Critical Illness
Obesity
Hypercapnia
Dyslipidemias
Hyperglycemia
Morbidity
Liver
Therapeutics

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Monitoring nutrition therapy in the critically Ill patient with obesity. / Dickerson, Roland; Drover, John W.

In: Journal of Parenteral and Enteral Nutrition, Vol. 35, No. 5 SUPPL., 01.09.2011.

Research output: Contribution to journalArticle

@article{e3f48029255e4adb8a9d902ba2320562,
title = "Monitoring nutrition therapy in the critically Ill patient with obesity",
abstract = "Obesity compounds the metabolic response to critical illness and augments the consequences of overfeeding. Effective monitoring is essential for the prevention of, or to avoid, worsening of preexistent morbidities associated with obesity during the implementation of specialized nutrition support. This monitoring should guide the clinician toward the selection of appropriate therapeutic options to reduce complications from significant hyperglycemia, dyslipidemia, hypercapnia, fluid overload, and worsening of hepatic steatosis. Conventional nutrition outcome markers should be employed, with their limitations understood, when used for the critically ill obese patient.",
author = "Roland Dickerson and Drover, {John W.}",
year = "2011",
month = "9",
day = "1",
doi = "10.1177/0148607111413771",
language = "English (US)",
volume = "35",
journal = "Journal of Parenteral and Enteral Nutrition",
issn = "0148-6071",
publisher = "SAGE Publications Inc.",
number = "5 SUPPL.",

}

TY - JOUR

T1 - Monitoring nutrition therapy in the critically Ill patient with obesity

AU - Dickerson, Roland

AU - Drover, John W.

PY - 2011/9/1

Y1 - 2011/9/1

N2 - Obesity compounds the metabolic response to critical illness and augments the consequences of overfeeding. Effective monitoring is essential for the prevention of, or to avoid, worsening of preexistent morbidities associated with obesity during the implementation of specialized nutrition support. This monitoring should guide the clinician toward the selection of appropriate therapeutic options to reduce complications from significant hyperglycemia, dyslipidemia, hypercapnia, fluid overload, and worsening of hepatic steatosis. Conventional nutrition outcome markers should be employed, with their limitations understood, when used for the critically ill obese patient.

AB - Obesity compounds the metabolic response to critical illness and augments the consequences of overfeeding. Effective monitoring is essential for the prevention of, or to avoid, worsening of preexistent morbidities associated with obesity during the implementation of specialized nutrition support. This monitoring should guide the clinician toward the selection of appropriate therapeutic options to reduce complications from significant hyperglycemia, dyslipidemia, hypercapnia, fluid overload, and worsening of hepatic steatosis. Conventional nutrition outcome markers should be employed, with their limitations understood, when used for the critically ill obese patient.

UR - http://www.scopus.com/inward/record.url?scp=84855427580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855427580&partnerID=8YFLogxK

U2 - 10.1177/0148607111413771

DO - 10.1177/0148607111413771

M3 - Article

VL - 35

JO - Journal of Parenteral and Enteral Nutrition

JF - Journal of Parenteral and Enteral Nutrition

SN - 0148-6071

IS - 5 SUPPL.

ER -